REQUEST A DEMO
Total
USD $0.00
Search more companies

Fujian Haixi Pharmaceuticals Co. Ltd. (福建海西新药创制股份有限公司) (China)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Fujian Haixi Pharmaceuticals Co. Ltd. Profile Updated: February 10, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Fujian Haixi Pharmaceuticals Co. Ltd. (福建海西新药创制股份有限公司) is an enterprise in China, with the main office in Fuzhou. It operates in the Pharmaceutical Preparation Manufacturing industry. It was established on April 04, 2026. In its most recent financial highlights, the company reported a net sales revenue increase of 47.39% in 2024. Its’ total assets recorded a growth of 34.6%. In 2024, Fujian Haixi Pharmaceuticals Co. Ltd. (福建海西新药创制股份有限公司)’s net profit margin decreased by 7.94%.

Headquarters
Floor 3 4, Block B, No. 177 Jinda Road, Jianxin Town, Cangshan District
Fuzhou; Jiangxi;

Contact Details: Purchase the Fujian Haixi Pharmaceuticals Co. Ltd. (福建海西新药创制股份有限公司) report to view the information.

Website: http://www.hxpharma.com

Basic Information
Outstanding Shares:
Purchase the Fujian Haixi Pharmaceuticals Co. Ltd. (福建海西新药创制股份有限公司) report to view the information.
Financial Auditors:
Purchase the Fujian Haixi Pharmaceuticals Co. Ltd. (福建海西新药创制股份有限公司) report to view the information.
Incorporation Date:
April 04, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Subsidiaries
Haixi New Drug Creation(/Br) (Fuzhou) Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Fujian Haixi Pharmaceuticals Co. Ltd. (福建海西新药创制股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
47.39%
Total Operating Revenue
47.02%
Operating Profit
11.49%
EBITDA
11.9%
Net Profit/Loss for the Period
15.86%
Total Assets
34.6%
Total Equity
33.58%
Operating Profit Margin
-10.32%
Net Profit Margin
-7.94%
Return on Equity (ROE)
-3.84%
Debt / Equity
2%
Quick Ratio
-932.62%
Cash Ratio
-1.96%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?